Search research articles
Contact Us
Filters
Showing results (541-550 of 942) with videos related to
Page
of 95
Sort By:
The Journal of Rheumatology
|
April 5, 2011
Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs
Christian T Ruff, David A Morrow, Peter Jarolim, et al.
Journal of the American College of Cardiology
|
September 11, 2004
Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction
Saihari Sadanandan, Christopher P Cannon, Kasi Chekuri, et al.
The American Journal of Cardiology
|
January 31, 2007
Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial)
Marc P Bonaca, Stephen D Wiviott, Marc S Sabatine, et al.
JACC. Cardiovascular Interventions
|
October 22, 2016
Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar: Insights From the TRA 2°P-TIMI 50 Trial
Marc P Bonaca, Mark A Creager, Jeffrey Olin, et al.
Journal of Neurology
|
January 14, 2024
Experiences of people with multiple sclerosis and clinicians in using cognitive behavioural therapies for hidden symptoms: a systematic review and meta-aggregation
Gregory Feng, Stephanie Posa, Ashvene Sureshkumar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 23, 2010
Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22
Marc P Bonaca, David A Morrow, Eugene Braunwald, et al.
Plos One
|
May 14, 2013
Characterization of the complete uric acid degradation pathway in the fungal pathogen Cryptococcus neoformans
I Russel Lee, Liting Yang, Gaseene Sebetso, et al.
The American Journal of Cardiology
|
November 25, 2000
Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II
J A de Lemos, E M Antman, R P Giugliano, et al.
Journal of the American College of Cardiology
|
April 18, 2009
Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial
Benjamin M Scirica, David A Morrow, Andrzej Budaj, et al.
European Heart Journal
|
April 24, 2010
Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial
Robert P Giugliano, Roberto R Giraldez, David A Morrow, et al.
Page
of 95
Search research articles
Search
Showing results (541-550 of 942) with videos related to
Sort By:
Page
of 95
The Journal of Rheumatology
|
April 5, 2011
Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs
Christian T Ruff, David A Morrow, Peter Jarolim, et al.
Journal of the American College of Cardiology
|
September 11, 2004
Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction
Saihari Sadanandan, Christopher P Cannon, Kasi Chekuri, et al.
The American Journal of Cardiology
|
January 31, 2007
Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial)
Marc P Bonaca, Stephen D Wiviott, Marc S Sabatine, et al.
JACC. Cardiovascular Interventions
|
October 22, 2016
Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar: Insights From the TRA 2°P-TIMI 50 Trial
Marc P Bonaca, Mark A Creager, Jeffrey Olin, et al.
Journal of Neurology
|
January 14, 2024
Experiences of people with multiple sclerosis and clinicians in using cognitive behavioural therapies for hidden symptoms: a systematic review and meta-aggregation
Gregory Feng, Stephanie Posa, Ashvene Sureshkumar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 23, 2010
Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22
Marc P Bonaca, David A Morrow, Eugene Braunwald, et al.
Plos One
|
May 14, 2013
Characterization of the complete uric acid degradation pathway in the fungal pathogen Cryptococcus neoformans
I Russel Lee, Liting Yang, Gaseene Sebetso, et al.
The American Journal of Cardiology
|
November 25, 2000
Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II
J A de Lemos, E M Antman, R P Giugliano, et al.
Journal of the American College of Cardiology
|
April 18, 2009
Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial
Benjamin M Scirica, David A Morrow, Andrzej Budaj, et al.
European Heart Journal
|
April 24, 2010
Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial
Robert P Giugliano, Roberto R Giraldez, David A Morrow, et al.
Page
of 95